Neuroleptic Agent Toxicity: A Comprehensive Review of Mechanisms, Clinical Manifestations, and Management Strategies

Neuroleptic agents, encompassing both first-generation and second-generation antipsychotics, represent a pharmacologically heterogeneous class of medications with expanding clinical applications beyond traditional psychiatric indications. While their therapeutic efficacy primarily derives from dopamine D2 receptor antagonism, the intricate interplay with serotonergic, histaminergic, adrenergic, and cholinergic receptor systems generates a complex spectrum of potential adverse effects. This comprehensive review examines the multifaceted nature of neuroleptic toxicity, integrating pharmacodynamic principles with clinical manifestations ranging from mild, self-limited symptoms to severe, life-threatening conditions such as neuroleptic malignant syndrome and malignant cardiac arrhythmias. The etiology of neuroleptic toxicity reflects drug-specific receptor-binding affinities, dose-related effects, exposure duration, and patient-specific vulnerabilities. Epidemiological data underscore the substantial public health burden imposed by these agents, with thousands of emergency department visits annually attributable to antipsychotic-related adverse events. The pathophysiology involves disruption of dopaminergic pathways in the nigrostriatal, tuberoinfundibular, and hypothalamic regions, coupled with effects on cardiac potassium channels and multiple neurotransmitter systems. Clinical recognition demands careful history-taking and physical examination, with particular attention to the temporal relationship between drug exposure and symptom onset. Management strategies emphasize individualized, patient-centered approaches incorporating dose reduction, medication switching, and targeted pharmacologic interventions. The expanding use of neuroleptic agents across diverse patient populations necessitates heightened clinical vigilance, robust monitoring protocols, and coordinated interprofessional collaboration to optimize outcomes while minimizing toxicity risk.